Literature DB >> 2514258

Epistaxis due to glutaraldehyde exposure.

P Wiggins1, S A McCurdy, W Zeidenberg.   

Abstract

Glutaraldehyde is commonly used as a cold disinfecting agent in the hospital setting and may cause irritation of skin, mucous membranes, and the upper respiratory tract in exposed workers. We report an unusual case of recurrent epistaxis associated with other symptoms of upper respiratory tract irritation and skin rash in a hospital employee using glutaraldehyde for sterilization of endoscopy equipment. A visit to the workplace revealed inadequate personal protective measures and inadequate local ventilation. High-risk work practices contributing to the hazard included soaking of endoscopy equipment in uncovered basins, manual pouring of concentrated glutaraldehyde solutions without the use of proper protective measures, and the use of paper masks, which provide inadequate protection from solvent vapors. The patient's symptoms resolved with the implementation of personal protective measures and engineering controls.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2514258     DOI: 10.1097/00043764-198910000-00013

Source DB:  PubMed          Journal:  J Occup Med        ISSN: 0096-1736


  4 in total

Review 1.  Occupational irritant and allergic rhinitis.

Authors:  Dennis Shusterman
Journal:  Curr Allergy Asthma Rep       Date:  2014-04       Impact factor: 4.806

2.  An assessment of exposure to glutaraldehyde in hospitals: typical exposure levels and recommended control measures.

Authors:  P Leinster; J M Baum; P J Baxter
Journal:  Br J Ind Med       Date:  1993-02

Review 3.  Toxicology of nasal irritants.

Authors:  Dennis Shusterman
Journal:  Curr Allergy Asthma Rep       Date:  2003-05       Impact factor: 4.919

4.  Comparison of Different Crosslinking Methods for Preparation of Docetaxel-loaded Albumin Nanoparticles.

Authors:  Hassan Niknejad; Raziyeh Mahmoudzadeh
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.